Literature DB >> 8726041

Sensitization of bacteria to danofloxacin by temperate prophages.

S Froshauer1, A M Silvia, M Chidambaram, B Sharma, G M Weinstock.   

Abstract

Danofloxacin (CP-76,136) is in a class of agents that inhibit DNA gyrase and trigger induction of the SOS response and temperate bacteriophages. Killing studies against the bovine pathogen Pasteurella haemolytica demonstrated that danofloxacin exhibits particularly rapid killing kinetics. Here, lysogenic Escherichia coli bearing lambda is found to be more sensitive to danofloxacin than nonlysogenic E. coli. Danofloxacin exposure also induced a prophage in P. haemolytica. The potency of danofloxacin against lysogens in likely enhanced by this prophage induction.

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8726041      PMCID： PMC163371          DOI： 10.1128/AAC.40.6.1561

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  8 in total

1.  Induction of the SOS response by new 4-quinolones.

Authors:  I Phillips; E Culebras; F Moreno; F Baquero
Journal:  J Antimicrob Chemother       Date:  1987-11       Impact factor: 5.790

Review 2.  Colicins and other bacteriocins with established modes of action.

Authors:  J Konisky
Journal:  Annu Rev Microbiol       Date:  1982       Impact factor: 15.500

Review 3.  The SOS regulatory system of Escherichia coli.

Authors:  J W Little; D W Mount
Journal:  Cell       Date:  1982-05       Impact factor: 41.582

4.  Analysis of gene control signals by DNA fusion and cloning in Escherichia coli.

Authors:  M J Casadaban; S N Cohen
Journal:  J Mol Biol       Date:  1980-04       Impact factor: 5.469

5.  Correlation of quinolone MIC and inhibition of DNA, RNA, and protein synthesis and induction of the SOS response in Escherichia coli.

Authors:  L J Piddock; R N Walters; J M Diver
Journal:  Antimicrob Agents Chemother       Date:  1990-12       Impact factor: 5.191

6.  A bacterial virulence determinant encoded by lysogenic coliphage lambda.

Authors:  J J Barondess; J Beckwith
Journal:  Nature       Date:  1990-08-30       Impact factor: 49.962

7.  Pasteurella haemolytica bacteriophage: identification, partial characterization, and relationship of temperate bacteriophages from isolates of Pasteurella haemolytica (biotype A, serotype 1).

Authors:  A B Richards; H W Renshaw; L W Sneed
Journal:  Am J Vet Res       Date:  1985-05       Impact factor: 1.156

8.  Synthesis and structure-activity relationships of 7-diazabicycloalkylquinolones, including danofloxacin, a new quinolone antibacterial agent for veterinary medicine.

Authors:  P R McGuirk; M R Jefson; D D Mann; N C Elliott; P Chang; E P Cisek; C P Cornell; T D Gootz; S L Haskell; M S Hindahl
Journal:  J Med Chem       Date:  1992-02-21       Impact factor: 7.446
  8 in total
  4 in total

1.  Autolysis and autoaggregation in Pseudomonas aeruginosa colony morphology mutants.

Authors:  David A D'Argenio; M Worth Calfee; Paul B Rainey; Everett C Pesci
Journal:  J Bacteriol       Date:  2002-12       Impact factor: 3.490

Review 2.  Mechanisms and Regulation of Extracellular DNA Release and Its Biological Roles in Microbial Communities.

Authors:  Alejandra L Ibáñez de Aldecoa; Olga Zafra; José E González-Pastor
Journal:  Front Microbiol       Date:  2017-07-26       Impact factor: 5.640

3.  Isolation and Characterization of Lytic Properties of Bacteriophages Specific for M. haemolytica Strains.

Authors:  Renata Urban-Chmiel; Andrzej Wernicki; Diana Stęgierska; Marta Dec; Anna Dudzic; Andrzej Puchalski
Journal:  PLoS One       Date:  2015-10-09       Impact factor: 3.240

4.  Non-Monotonic Survival of Staphylococcus aureus with Respect to Ciprofloxacin Concentration Arises from Prophage-Dependent Killing of Persisters.

Authors:  Elizabeth L Sandvik; Christopher H Fazen; Theresa C Henry; Wendy W K Mok; Mark P Brynildsen
Journal:  Pharmaceuticals (Basel)       Date:  2015-11-17
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.